| Financial Year |
March 31 2023 |
| Monetary Funds |
190,348,268.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,054,491.85 |
| Accounts Receivable |
96,547,633.96 |
| Advances to Suppliers |
71,644,833.69 |
| Other Receivables |
136,344,216.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,040,198.71 |
| Dividend Receivable |
-- |
| Inventories |
296,523,321.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,644,500.14 |
| Total Current Assets |
814,107,265.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,455,287.25 |
| Investment Properties |
476,722,004.85 |
| Fixed Assetes |
1,500,760,500.97 |
| Under-construction Projects |
57,116,042.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
122,039,632.57 |
| R&D expenses |
-- |
| Goodwill |
139,677,235.42 |
| Long-Term Deferred and Prepaid Expenses |
337,832,319.20 |
| Deferred Income Tax Assets |
43,729,690.91 |
| Other Non-Current Assets |
316,375,514.80 |
| Sub-Total of Non-Current Assets |
3,442,529,599.73 |
| Total Assets |
4,256,636,865.37 |
| Short-Term Loans |
925,059,756.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,144,444.70 |
| Accounts Payable |
516,525,143.78 |
| Accounts Received In Advance |
47,810,893.16 |
| Employee Compensation Payable |
29,772,746.76 |
| Taxes Payable |
24,242,489.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
314,445,001.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,736,434.49 |
| Other Current Liabilities |
58,743,009.98 |
| Sub-Total of Current Liabilities |
2,423,621,292.15 |
| Long-term Loans |
13,726,500.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
90,926,254.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
446,941,960.28 |
| Total Liabilities |
2,870,563,252.43 |
| Paid-In Capital(Or Share Stock) |
470,400,000.00 |
| Capital Surplus |
210,127,416.08 |
| Surplus Reserve |
41,223,431.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
667,495,257.20 |
| Minority Stockholder's Interest |
-3,172,491.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,389,246,104.87 |
| Owner's Equity（Stockholder's Equity） |
1,386,073,612.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,256,636,865.37 |
